NYSE:VSI - Vitamin Shoppe Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $5.11 -0.06 (-1.16 %) (As of 01/16/2019 06:00 AM ET)Previous Close$5.17Today's Range$4.97 - $5.2052-Week Range$3.50 - $13.95Volume403,883 shsAverage Volume480,228 shsMarket Capitalization$125.39 millionP/E Ratio13.10Dividend YieldN/ABeta1.36 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Vitamin Shoppe, Inc., through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products. It offers vitamins, minerals, herbs, specialty supplements, sports nutrition products, and other health and wellness products of approximately 900 brands, such as own brands comprising The Vitamin Shoppe, BodyTech, True Athlete, Mytrition, plnt, ProBioCare, Next Step, and Betancourt Nutrition; and national brands, including Optimum Nutrition, Cellucor, Garden of Life, Quest Nutrition, Solaray, Solgar, Megafood, and Nature's Way. The company sells its products through Vitamin Shoppe and Super Supplements retail stores, as well as through its vitaminshoppe.com Website. As of November 7, 2018, it operated 775 company-operated retail stores under the Vitamin Shoppe and Super Supplements retail banners. It also operates franchise stores. The company was formerly known as VS Holdings, Inc. and changed its name to Vitamin Shoppe, Inc. in November 2009. Vitamin Shoppe, Inc. was founded in 1977 and is headquartered in Secaucus, New Jersey. Receive VSI News and Ratings via Email Sign-up to receive the latest news and ratings for VSI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Food stores Sub-IndustrySpecialty Stores SectorRetail/Wholesale Current SymbolNYSE:VSI Previous Symbol CUSIP92849E10 Webwww.vitaminshoppe.com Phone201-868-5959Debt Debt-to-Equity Ratio0.32 Current Ratio2.23 Quick Ratio0.41Price-To-Earnings Trailing P/E Ratio13.10 Forward P/E Ratio28.39 P/E GrowthN/A Sales & Book Value Annual Sales$1.18 billion Price / Sales0.10 Cash Flow$13.1026 per share Price / Cash Flow0.39 Book Value$8.15 per share Price / Book0.63Profitability EPS (Most Recent Fiscal Year)$0.39 Net Income$-252,150,000.00 Net Margins-1.41% Return on Equity3.48% Return on Assets1.51%Miscellaneous Employees5,573 Outstanding Shares24,020,000Market Cap$125.39 million OptionableOptionable Vitamin Shoppe (NYSE:VSI) Frequently Asked Questions What is Vitamin Shoppe's stock symbol? Vitamin Shoppe trades on the New York Stock Exchange (NYSE) under the ticker symbol "VSI." How were Vitamin Shoppe's earnings last quarter? Vitamin Shoppe Inc (NYSE:VSI) issued its quarterly earnings results on Wednesday, November, 7th. The specialty retailer reported $0.04 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.08. The specialty retailer earned $276.64 million during the quarter, compared to the consensus estimate of $278.79 million. Vitamin Shoppe had a positive return on equity of 3.48% and a negative net margin of 1.41%. View Vitamin Shoppe's Earnings History. When is Vitamin Shoppe's next earnings date? Vitamin Shoppe is scheduled to release their next quarterly earnings announcement on Tuesday, February 26th 2019. View Earnings Estimates for Vitamin Shoppe. What price target have analysts set for VSI? 2 brokerages have issued 12-month target prices for Vitamin Shoppe's shares. Their forecasts range from $14.00 to $14.00. On average, they anticipate Vitamin Shoppe's stock price to reach $14.00 in the next twelve months. This suggests a possible upside of 174.0% from the stock's current price. View Analyst Price Targets for Vitamin Shoppe. What is the consensus analysts' recommendation for Vitamin Shoppe? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vitamin Shoppe in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Vitamin Shoppe. Has Vitamin Shoppe been receiving favorable news coverage? Press coverage about VSI stock has trended negative recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Vitamin Shoppe earned a news sentiment score of -2.5 on InfoTrie's scale. They also assigned headlines about the specialty retailer a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an effect on the stock's share price in the next few days. Who are some of Vitamin Shoppe's key competitors? Some companies that are related to Vitamin Shoppe include J Sainsbury (JSAIY), WM MORRISON SUP/ADR (MRWSY), CECONOMY AG/ADR (MTTRY), GNC (GNC), DavidsTea (DTEA), Green Polkadot Box (GPDB) and Crumbs Bake Shop (CRMBQ). Who are Vitamin Shoppe's key executives? Vitamin Shoppe's management team includes the folowing people: Mr. David M. Kastin, Sr. VP, Gen. Counsel & Corp. Sec. (Age 50)Ms. Sharon M. Leite, CEO & Director (Age 55)Mr. Bill Wafford, Exec. VP & CFO (Age 46)Mr. Charles D. Knight, Sr. VP, Chief Accounting Officer & Corp. Controller (Age 54)Mr. David Morrison, VP of Scientific & Regulatory Affairs Who are Vitamin Shoppe's major shareholders? Vitamin Shoppe's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Shah Capital Management (17.38%). Company insiders that own Vitamin Shoppe stock include Alex Smith, B Michael Becker, Dan Lamadrid, Guillermo Marmol, John D Bowlin, Richard L Markee, Shah Capital Management, Sharon M Leite and Vintage Capital Management Llc. View Institutional Ownership Trends for Vitamin Shoppe. Which major investors are selling Vitamin Shoppe stock? VSI stock was sold by a variety of institutional investors in the last quarter, including Shah Capital Management. View Insider Buying and Selling for Vitamin Shoppe. How do I buy shares of Vitamin Shoppe? Shares of VSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Vitamin Shoppe's stock price today? One share of VSI stock can currently be purchased for approximately $5.11. How big of a company is Vitamin Shoppe? Vitamin Shoppe has a market capitalization of $125.39 million and generates $1.18 billion in revenue each year. The specialty retailer earns $-252,150,000.00 in net income (profit) each year or $0.39 on an earnings per share basis. Vitamin Shoppe employs 5,573 workers across the globe. What is Vitamin Shoppe's official website? The official website for Vitamin Shoppe is http://www.vitaminshoppe.com. How can I contact Vitamin Shoppe? Vitamin Shoppe's mailing address is 300 HARMON MEADOW BLVD., SECAUCUS NJ, 07094. The specialty retailer can be reached via phone at 201-868-5959 or via email at [email protected] MarketBeat Community Rating for Vitamin Shoppe (NYSE VSI)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 320 (Vote Outperform)Underperform Votes: 470 (Vote Underperform)Total Votes: 790MarketBeat's community ratings are surveys of what our community members think about Vitamin Shoppe and other stocks. Vote "Outperform" if you believe VSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VSI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/16/2019 by MarketBeat.com StaffFeatured Article: What are the reasons investors use put options?